Form 4: Quest Diagnostics SVP, Clinical Solutions, Reports Stock Transactions
SEC Form 4 Filing
Karthik Kuppusamy, SVP at Quest Diagnostics, reports disposition of shares to cover tax obligations and holdings in a 401(k) plan.
Summary
- Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership.
- On February 19, 2025, Kuppusamy disposed of 287 shares of common stock at a price of $169.71 to cover tax withholding obligations related to vesting restricted stock units.
- Following the transaction, Kuppusamy directly owns 11,779 shares of Quest Diagnostics common stock.
- Kuppusamy also indirectly owns 358 shares through a trust and 1,591 shares through the company's 401(k) plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document is a standard SEC filing detailing stock transactions for tax purposes.
Industry Context
This filing is a routine disclosure related to executive stock transactions and is typical for publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has minimal direct impact on stakeholders as it is a routine stock disposition for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of stock disposition for tax obligations. |
| 02/21/2025 | Date of signature by Attorney in Fact. |
Keywords
Form 4, Quest Diagnostics, Karthik Kuppusamy, Beneficial Ownership, Stock Transaction, DGX, SVP Clinical Solutions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.